METHOD FOR DIFFERENTIAL DIAGNOSTICS OF MAMMARY GLAND CANCER AND CENTRAL BROKEN BREAST Russian patent published in 2008 - IPC A61B10/00 G01N33/48 

Abstract RU 2336823 C1

FIELD: medicine.

SUBSTANCE: examination of patient is carried out at which the following indicators are defined: social status, accompanying diseases, oncological anamnesis, blood monocytes, speed of subsidence of erythrocytes (SSE), hemoglobin, specific weight of urine, urine reaction. Then diagnostic coefficient (DC) for each indicator is defined. Social status at marker - workers diagnostic coefficient equal to (-3.5) is established in the system, at marker employees - equal to (0), at marker pupils - equal to (0), at marker the unemployed - equal to (0), at marker pensioners and disabled workers (DW) - equal to (+4). Accompanying diseases at marker - diseases of gastroenteric tract (GET) DC equal to (-5), is established in the system, at marker of disease of cardiovascular system - equal to (+5.5), at marker of disease of endocrine system - equal to (-3,5), at marker of disease of respiratory system - equal to (+2), at marker of disease of locomotor apparatus - equal to (0), at marker of disease of urogenital system - equal to (0), at marker of a combination of accompanying diseases - equal to (+8), at marker of absence of accompanying diseases - equal to (-3). Oncological anamnesis at marker - available, DC equal to (0) is established in the system, at marker absent - equal to(-1). Monocytes at marker - not present, DC equal to (0) is established in the system, at marker of 1-3% - equal to (+0.5), at marker of 4-6% - equal to (-1.5), at marker of 7-10% - equal to (+4), at marker more than 10% - equal to (0). od sedimentation rate at marker - 1-10 mm per hour DC equal to (-2.5) is established in the system, at marker of 11-20 mm per hour - equal to (-0.5), at marker of 21-30 mm per hour - equal to (+7), at marker of 31-40 mm per hour - equal to (0), at marker more than 40 mm per hour - equal to (-1). Hemoglobin at marker - less than 100 gram per l. DC equal to (0) is established in the system, at marker 100-120 gram per l. - equal to(+6), at marker more than 120 gram per l. - equal to(-4). Specific weight of urine at marker less than 1008 DC equal to (0 is established in the system, at marker 1008-1026 - equal to (-0.5), at marker more than 1026 - equal to (+6). Urine reaction at marker - sour, DC equal to (+1), is established in the system, at marker neutral - equal to (-10), at marker alkaline - equal to (0). If DC sum is from (+6) and more, diagnosis of mammary gland cancer is proved to be true, if the sum is (-12) and less, diagnosis of central broken breast is proved to be true. This way allows to differentiate cancer of mammary gland and central broken breast at the stage of laboratory examination and will be applied in early diagnostics of cancer of mammary gland, with use of such indicators as: social status, accompanying diseases, oncological anamnesis, blood monocytes, blood sedimentation rate, hemoglobin, specific weight of urine, urine reaction, it distinguish itself by availability and simplicity of calculations.

EFFECT: working out of means of diagnostics of mammary gland cancer initially.

3 tbl, 2 ex

Similar patents RU2336823C1

Title Year Author Number
METHOD FOR MAMMARY GLAND CANCER FORECASTING 2007
  • Levchenko Kirill Fedorovich
  • Magarill Jurij Abramovich
  • Belogorlova Tamara Ivanovna
  • Krajushkina Nadezhda Aleksandrovna
RU2336822C1
METHOD FOR PREDICTION OF RISK OF DETECTION OF MINOR BREAST CANCER ACCOMPANYING FIBROCYSTIC BREAST DISEASE 2013
  • Bukharin Dmitrij Gennad'Evich
  • Velichko Svetlana Andreevna
  • Slonimskaja Elena Mikhajlovna
  • Frolova Irina Georgievna
  • Doroshenko Artem Vasil'Evich
  • Tolmachev Ivan Vladislavovich
RU2547802C2
METHOD FOR PREDICTION OF BREAST CANCER STAGES 2008
  • Levchenko Kirill Fedorovich
  • Chernobaj Georgij Nikolaevich
RU2393474C1
MEANS FOR BREAST CANCER PREDICTION 2016
  • Malashenko Viktor Nikolaevich
  • Balnykov Sergej Igorevich
  • Sgonnik Anna Vladimirovna
RU2631940C1
METHOD FOR PREDICTION OF BREAST CANCER RISK DEVELOPMENT IN OBESE WOMEN 2022
  • Churnosov Mikhail Ivanovich
  • Pavlova Nadezhda Vitalevna
  • Elykova Anna Vladimirovna
RU2795244C1
METHOD FOR PREDICTION OF BREAST CANCER RISK DEVELOPMENT IN NON-OBESE WOMEN 2023
  • Churnosov Mikhail Ivanovich
  • Pavlova Nadezhda Vitalevna
  • Elykova Anna Vladimirovna
  • Ponomarenko Irina Vasilevna
  • Churnosova Mariia Mikhailovna
RU2795726C1
METHOD FOR PREDICTION OF RISK OF DEVELOPING BREAST CANCER IN WOMEN BASED ON DATA ON INTERLOCUS INTERACTIONS 2023
  • Churnosov Mikhail Ivanovich
  • Pasenov Konstantin Nikolaevich
  • Elykova Anna Vladimirovna
  • Ponomarenko Irina Vasilevna
  • Churnosova Mariia Mikhailovna
  • Ponomarenko Marina Sergeevna
  • Churnosov Vladimir Ivanovich
RU2815932C1
METHOD OF PREDICTING A LOW RISK OF DEVELOPING BREAST CANCER IN WOMEN WITH HIGHLY PENETRATING MUTATIONS IN THE BRCA1 AND CHEK2 GENES 2022
  • Churnosov Mikhail Ivanovich
  • Pavlova Nadezhda Vitalevna
  • Elykova Anna Vladimirovna
RU2798666C1
METHOD OF PREDICTING RISK OF DEVELOPING TRIPLE-NEGATIVE BREAST CANCER 2023
  • Churnosov Mikhail Ivanovich
  • Pavlova Nadezhda Vitalevna
  • Elykova Anna Vladimirovna
  • Ponomarenko Irina Vasilevna
RU2811257C1
METHOD FOR PREDICTING THE RISK OF DEVELOPMENT OF THE LUMINAL SUBTYPE OF BREAST CANCER 2023
  • Churnosov Mikhail Ivanovich
  • Pavlova Nadezhda Vitalevna
  • Elykova Anna Vladimirovna
  • Ponomarenko Irina Vasilevna
RU2795720C1

RU 2 336 823 C1

Authors

Levchenko Kirill Fedorovich

Magarill Jurij Abramovich

Belogorlova Tamara Ivanovna

Krajushkina Nadezhda Aleksandrovna

Dates

2008-10-27Published

2007-04-05Filed